Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
297K
-
Shares change
-
+224K
-
Total reported value, excl. options
-
$8.53M
-
Value change
-
+$6.44M
-
Number of buys
-
4
-
Number of sells
-
-1
-
Price
-
$29.02
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q4 2023
5 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q4 2023.
Revolution Medicines, Inc. - Common Stock (RVMD) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 297K shares
of 186M outstanding shares and own 0.16% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (14.9M shares), VANGUARD GROUP INC (14.6M shares), BlackRock Inc. (13M shares), FARALLON CAPITAL MANAGEMENT LLC (6.74M shares), Nextech Invest Ltd. (6.3M shares), STATE STREET CORP (6.25M shares), BVF INC/IL (5.98M shares), Casdin Capital, LLC (5.71M shares), AH Capital Management, L.L.C. (5.7M shares), and Alphabet Inc. (5.3M shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.